Axiota Animal Health, Resilient Biotics to co-develop BRD technology

Axiota Animal Health, a global animal health company based in Colorado, announced this week a development and licensing agreement with Resilient Biotics, a North Carolina-based company pioneering new microbiome-based animal products using advanced multi-omic approaches, data science, and in vitro screening technologies. The agreement grants Axiota exclusive global rights to Resilient Biotics’ proprietary treatment of bovine respiratory disease (BRD) and further collaboration with Resilient Biotics for additional product development and commercialization of important indications in the…